HSD17B13 Antikörper (AA 59-300)
Kurzübersicht für HSD17B13 Antikörper (AA 59-300) (ABIN7875898)
Target
Alle HSD17B13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 59-300
-
Verwendungszweck
- HSD17B13 Antibody / 17-beta-HSD 13 / SCDR9
-
Aufreinigung
- Antigen affinity chromatography
-
Immunogen
- An E.coli-derived human recombinant protein (amino acids R59-K300) was used as the immunogen for the HSD17B13 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the HSD17B13 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the HSD17B13 Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))
-
Andere Bezeichnung
- HSD17B13
-
Hintergrund
- 17-beta-Hydroxysteroid dehydrogenase type 13 also known as 17-beta-HSD type 13 is an enzyme that in humans is encoded by the HSD17B13 gene. Hydroxysteroid (17-beta) dehydrogenase 13, also designated Short-chain dehydrogenase/reductase 9 (SCDR9), which regulate the availability of steroids within various tissues throughout the body. HSD17B13 is a 300 amino acid secreted protein that is highly expressed in liver and is also detected in ovary, bone marrow, kidney, brain, lung, skeletal muscle, bladder and testis. The gene encoding HSD17B13 maps to chromosome 4, which houses nearly 6 % of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease.
-
UniProt
- Q7Z5P4
Target
-